# Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections

> **NCT03802552** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 17 (actual)

## Conditions studied

- Osteomyelitis
- Septic Arthritis
- Pyomyositis

## Interventions

- **DRUG:** Cefadroxil
- **DRUG:** Cephalexin

## Key facts

- **NCT ID:** NCT03802552
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03802552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03802552, "Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03802552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*